Clincosm LogoSign in Get a demo

Gastrointestinal Stromal Tumors

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Research of Drug Holiday Based on MRD Detection in GIST

Recruiting
  • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
      Peking University People's Hospital
    May 11, 2023

    Ripretinib in Chinese Advanced GIST: a Real World Study

    Active, not recruiting
    • Gastrointestinal Stromal Tumors
    • Ripretinib Oral Tablet
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 15, 2023

    Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Minimal Residual Disease
    • liquid biopsy
    • Beijing, Beijing, China
      Peking University People'S Hospital
    Sep 18, 2022

    Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Avapritinib
    • Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Sep 14, 2022

    Gastrointestinal Stromal Tumors Trial in China (DCC-2618)

    Completed
    • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
    • +8 more
    Aug 26, 2022

    Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients

    Completed
    • GIST
    • Gastrointestinal Stromal Tumors
      • Beijing, China
      • +2 more
      Jun 1, 2022

      Gastrointestinal Stromal Tumors Trial in Beijing, Guangzhou (CS3007 (BLU-285))

      Active, not recruiting
      • Gastrointestinal Stromal Tumors
      • CS3007 (BLU-285)
      • Beijing, Beijing, China
      • +1 more
      Apr 25, 2022

      Gastrointestinal Stromal Tumors Trial in Beijing (68Ga-NOTA-RM26)

      Recruiting
      • Gastrointestinal Stromal Tumors
      • Beijing, Beijing, China
        Peking Union Medical College Hospital, Chinese Academy of Medica
      Aug 6, 2021

      Gastrointestinal Stromal Tumors Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo, Best supportive care)

      Completed
      Has Results
      • Gastrointestinal Stromal Tumors
      • Regorafenib (Stivarga, BAY73-4506)
      • +2 more
      • Scottsdale, Arizona
      • +56 more
      Jan 27, 2021

      Gastrointestinal Stromal Tumors Trial in Beijing (Famitinib capsules, Sunitinib Capsules)

      Recruiting
      • Gastrointestinal Stromal Tumors
      • Famitinib capsules
      • Sunitinib Capsules
      • Beijing, China
        307 Hospital of PLA
      Nov 30, 2020

      Biliary Tract Tumors, Gastric Cancer, Esophageal Squamous Cell Carcinoma Trial in Beijing (FGFR Inhibitor, IDH1 Inhibitor, HER2

      Unknown status
      • Biliary Tract Neoplasms
      • +8 more
      • FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
      • Other Therapy
      • Beijing, Beijing, China
        Peking University Cancer Hospital
      Oct 8, 2020

      Gastrointestinal Stromal Tumors Trial in Beijing (Anlotinib)

      Unknown status
      • Gastrointestinal Stromal Tumors
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Sep 25, 2019

      Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Imatinib)

      Terminated
      Has Results
      • Gastrointestinal Stromal Tumors
      • Caba, Buenos Aires, Argentina
      • +31 more
      Feb 25, 2014